Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|
| Total reported revenue | 0 | 0 | 0 | 0 |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 81.6K | 88.4K | 155.7K | 462.6K |
| Other operating expenses | 50.4K | 19.1K | 33.9K | 130.2K |
| Operating income | -131.9K | -107.5K | -189.6K | -592.8K |
| Non operating interest income | ||||
| Income | 1.2K | 3.1K | 1.3K | 1.8K |
| Expense | — | — | — | — |
| Other income expense | -10.6K | -41.8K | -19.1K | -12.0K |
| Pretax income | -141.4K | -146.2K | -207.4K | -603.0K |
| Tax provision | — | — | — | — |
| Net income | -141.4K | -146.2K | -207.4K | -603.0K |
| Basic EPS | 0 | 0 | 0 | 0.0 |
| Diluted EPS | 0 | 0 | 0 | 0.0 |
| Basic average shares | 111.6M | 110.3M | 110.1M | 107.8M |
| Diluted average shares | 111.6M | 110.3M | 110.1M | 107.8M |
| EBITDA | -121.3K | -65.7K | -170.5K | -580.8K |
| Net income from continuing op. | -142.0K | -146.2K | -207.4K | -603.0K |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |